Xopenex
Product Images NDC 17478-174

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Xopenex (NDC 17478-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xop07 0005 01

FDA Label Image

Xop07 0005 02

FDA Label Image

Xop07 0005 03

FDA Label Image

Xop07 0005 04

FDA Label Image

Xop07 0005 05

FDA Label Image

Xop07 0005 06

The text states "Shaded area indicates twist-off tab portion of vial." It may be a label or instruction on a vial indicating where to twist to open it.*

FDA Label Image

Xop07 0005 07

FDA Label Image

Xop07 0005 08

FDA Label Image

Xop07 0005 09

FDA Label Image

Xop07 0005 10

FDA Label Image

Xop07 0005 11

FDA Label Image

Xop07 0005 12

FDA Label Image

Xop07 0005 13

FDA Label Image

Xop07 0005 14

FDA Label Image

Xop07 0005 15

This is a pharmaceutical product containing levalbuterol hydrochloride used for inhalation. The medication is provided in unit-dose vials, and each vial contains 0.31 mg of the medication. This inhalation solution should be used as directed by a physician and should not be used beyond the recommended dosage. The medication must be protected from light and stored at a controlled room temperature of 20 to 25°C (68° to 77°F). The individual vials should be used within one week of being removed from the protective foil pouch. Once the foil pouch is opened, the unit-dose vials should be used within two weeks.*

FDA Label Image

Xop07 0005 16

FDA Label Image

Xop07 0005 17

This is a medical product information leaflet for AKN1024-801R00 containing the NDC code, description of potency, storage instructions, and directions for use. It is a unit-dose vial used to treat bronchospasm and is to be stored in a foil pouch at a controlled room temperature between 20° to 25°C. The pharmacist must detach the patient instructions for use before dispensing, and it is not recommended to exceed the recommended dosage. The solution in the vials should be colourless, and the vials should be discarded if not used within two weeks after opening the foil pouch.*

FDA Label Image

Xop07 0005 18

FDA Label Image

Xop07 0005 19

This is a product description for a medication called Xopenex (levalbuterol HCl) Inhalation Solution. Each unit dose vial contains 1.25 mg of levalbuterol in an aqueous solution. The solution is free of preservatives and should be used as directed by a physician. The vials should be stored in the protective foil pouch and used within two weeks of opening. The medication should be discarded if the solution is not colorless. The product is distributed by Akon, Inc. for Oak Pharmaceuticals Inc.*

FDA Label Image

Xop07 0005 20

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.